Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors

Shashank R. Sirsi, Sonia L. Hernandez, Lukasz Zielinski, Henning Blomback, Adel Koubaa, Milo Synder, Shunichi Homma, Jessica J. Kandel, Darrell J. Yamashiro, Mark A. Borden

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Microbubble ultrasound contrast agents are being developed as image-guided gene carriers for targeted delivery in vivo. In this study, novel polyplex-microbubbles were synthesized, characterized and evaluated for systemic circulation and tumor transfection. Branched polyethylenimine (PEI; 25 kDa) was modified with polyethylene glycol (PEG; 5 kDa), thiolated and covalently attached to maleimide groups on lipid-coated microbubbles. The PEI-microbubbles demonstrated increasingly positive surface charge and DNA loading capacity with increasing maleimide content. The in vivo ultrasound contrast persistence of PEI-microbubbles was measured in the healthy mouse kidney, and a two-compartment pharmacokinetic model accounting for free and adherent microbubbles was developed to describe the anomalous time-intensity curves. The model suggested that PEI loading dramatically reduced free circulation and increased nonspecific adhesion to the vasculature. However, DNA loading to form polyplex-microbubbles increased circulation in the bloodstream and decreased nonspecific adhesion. PEI-microbubbles coupled to a luciferase bioluminescence reporter plasmid DNA were shown to transfect tumors implanted in the mouse kidney. Site-specific delivery was achieved using ultrasound applied over the tumor area following bolus injection of the DNA/PEI-microbubbles. In vivo imaging showed over 10-fold higher bioluminescence from the tumor region compared to untreated tissue. Ex vivo analysis of excised tumors showed greater than 40-fold higher expression in tumor tissue than non-sonicated control (heart) tissue. These results suggest that the polyplex-microbubble platform offers improved control of DNA loading and packaging suitable for ultrasound-guided tissue transfection.

Original languageEnglish (US)
Pages (from-to)224-234
Number of pages11
JournalJournal of Controlled Release
Volume157
Issue number2
DOIs
StatePublished - Jan 30 2012

Fingerprint

Microbubbles
Plasmids
DNA
Neoplasms
Transfection
DNA Packaging
Kidney
Polyethyleneimine
Luciferases
Contrast Media
Pharmacokinetics
Lipids

Keywords

  • Gene delivery
  • Polyethylene glycol
  • Polyethylenimine
  • Theranostic
  • Tumor
  • Ultrasound contrast agent

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Sirsi, S. R., Hernandez, S. L., Zielinski, L., Blomback, H., Koubaa, A., Synder, M., ... Borden, M. A. (2012). Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. Journal of Controlled Release, 157(2), 224-234. https://doi.org/10.1016/j.jconrel.2011.09.071

Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. / Sirsi, Shashank R.; Hernandez, Sonia L.; Zielinski, Lukasz; Blomback, Henning; Koubaa, Adel; Synder, Milo; Homma, Shunichi; Kandel, Jessica J.; Yamashiro, Darrell J.; Borden, Mark A.

In: Journal of Controlled Release, Vol. 157, No. 2, 30.01.2012, p. 224-234.

Research output: Contribution to journalArticle

Sirsi, SR, Hernandez, SL, Zielinski, L, Blomback, H, Koubaa, A, Synder, M, Homma, S, Kandel, JJ, Yamashiro, DJ & Borden, MA 2012, 'Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors', Journal of Controlled Release, vol. 157, no. 2, pp. 224-234. https://doi.org/10.1016/j.jconrel.2011.09.071
Sirsi, Shashank R. ; Hernandez, Sonia L. ; Zielinski, Lukasz ; Blomback, Henning ; Koubaa, Adel ; Synder, Milo ; Homma, Shunichi ; Kandel, Jessica J. ; Yamashiro, Darrell J. ; Borden, Mark A. / Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. In: Journal of Controlled Release. 2012 ; Vol. 157, No. 2. pp. 224-234.
@article{1dd8a71106ec422badcdd2554fcd971b,
title = "Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors",
abstract = "Microbubble ultrasound contrast agents are being developed as image-guided gene carriers for targeted delivery in vivo. In this study, novel polyplex-microbubbles were synthesized, characterized and evaluated for systemic circulation and tumor transfection. Branched polyethylenimine (PEI; 25 kDa) was modified with polyethylene glycol (PEG; 5 kDa), thiolated and covalently attached to maleimide groups on lipid-coated microbubbles. The PEI-microbubbles demonstrated increasingly positive surface charge and DNA loading capacity with increasing maleimide content. The in vivo ultrasound contrast persistence of PEI-microbubbles was measured in the healthy mouse kidney, and a two-compartment pharmacokinetic model accounting for free and adherent microbubbles was developed to describe the anomalous time-intensity curves. The model suggested that PEI loading dramatically reduced free circulation and increased nonspecific adhesion to the vasculature. However, DNA loading to form polyplex-microbubbles increased circulation in the bloodstream and decreased nonspecific adhesion. PEI-microbubbles coupled to a luciferase bioluminescence reporter plasmid DNA were shown to transfect tumors implanted in the mouse kidney. Site-specific delivery was achieved using ultrasound applied over the tumor area following bolus injection of the DNA/PEI-microbubbles. In vivo imaging showed over 10-fold higher bioluminescence from the tumor region compared to untreated tissue. Ex vivo analysis of excised tumors showed greater than 40-fold higher expression in tumor tissue than non-sonicated control (heart) tissue. These results suggest that the polyplex-microbubble platform offers improved control of DNA loading and packaging suitable for ultrasound-guided tissue transfection.",
keywords = "Gene delivery, Polyethylene glycol, Polyethylenimine, Theranostic, Tumor, Ultrasound contrast agent",
author = "Sirsi, {Shashank R.} and Hernandez, {Sonia L.} and Lukasz Zielinski and Henning Blomback and Adel Koubaa and Milo Synder and Shunichi Homma and Kandel, {Jessica J.} and Yamashiro, {Darrell J.} and Borden, {Mark A.}",
year = "2012",
month = "1",
day = "30",
doi = "10.1016/j.jconrel.2011.09.071",
language = "English (US)",
volume = "157",
pages = "224--234",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors

AU - Sirsi, Shashank R.

AU - Hernandez, Sonia L.

AU - Zielinski, Lukasz

AU - Blomback, Henning

AU - Koubaa, Adel

AU - Synder, Milo

AU - Homma, Shunichi

AU - Kandel, Jessica J.

AU - Yamashiro, Darrell J.

AU - Borden, Mark A.

PY - 2012/1/30

Y1 - 2012/1/30

N2 - Microbubble ultrasound contrast agents are being developed as image-guided gene carriers for targeted delivery in vivo. In this study, novel polyplex-microbubbles were synthesized, characterized and evaluated for systemic circulation and tumor transfection. Branched polyethylenimine (PEI; 25 kDa) was modified with polyethylene glycol (PEG; 5 kDa), thiolated and covalently attached to maleimide groups on lipid-coated microbubbles. The PEI-microbubbles demonstrated increasingly positive surface charge and DNA loading capacity with increasing maleimide content. The in vivo ultrasound contrast persistence of PEI-microbubbles was measured in the healthy mouse kidney, and a two-compartment pharmacokinetic model accounting for free and adherent microbubbles was developed to describe the anomalous time-intensity curves. The model suggested that PEI loading dramatically reduced free circulation and increased nonspecific adhesion to the vasculature. However, DNA loading to form polyplex-microbubbles increased circulation in the bloodstream and decreased nonspecific adhesion. PEI-microbubbles coupled to a luciferase bioluminescence reporter plasmid DNA were shown to transfect tumors implanted in the mouse kidney. Site-specific delivery was achieved using ultrasound applied over the tumor area following bolus injection of the DNA/PEI-microbubbles. In vivo imaging showed over 10-fold higher bioluminescence from the tumor region compared to untreated tissue. Ex vivo analysis of excised tumors showed greater than 40-fold higher expression in tumor tissue than non-sonicated control (heart) tissue. These results suggest that the polyplex-microbubble platform offers improved control of DNA loading and packaging suitable for ultrasound-guided tissue transfection.

AB - Microbubble ultrasound contrast agents are being developed as image-guided gene carriers for targeted delivery in vivo. In this study, novel polyplex-microbubbles were synthesized, characterized and evaluated for systemic circulation and tumor transfection. Branched polyethylenimine (PEI; 25 kDa) was modified with polyethylene glycol (PEG; 5 kDa), thiolated and covalently attached to maleimide groups on lipid-coated microbubbles. The PEI-microbubbles demonstrated increasingly positive surface charge and DNA loading capacity with increasing maleimide content. The in vivo ultrasound contrast persistence of PEI-microbubbles was measured in the healthy mouse kidney, and a two-compartment pharmacokinetic model accounting for free and adherent microbubbles was developed to describe the anomalous time-intensity curves. The model suggested that PEI loading dramatically reduced free circulation and increased nonspecific adhesion to the vasculature. However, DNA loading to form polyplex-microbubbles increased circulation in the bloodstream and decreased nonspecific adhesion. PEI-microbubbles coupled to a luciferase bioluminescence reporter plasmid DNA were shown to transfect tumors implanted in the mouse kidney. Site-specific delivery was achieved using ultrasound applied over the tumor area following bolus injection of the DNA/PEI-microbubbles. In vivo imaging showed over 10-fold higher bioluminescence from the tumor region compared to untreated tissue. Ex vivo analysis of excised tumors showed greater than 40-fold higher expression in tumor tissue than non-sonicated control (heart) tissue. These results suggest that the polyplex-microbubble platform offers improved control of DNA loading and packaging suitable for ultrasound-guided tissue transfection.

KW - Gene delivery

KW - Polyethylene glycol

KW - Polyethylenimine

KW - Theranostic

KW - Tumor

KW - Ultrasound contrast agent

UR - http://www.scopus.com/inward/record.url?scp=84855813934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855813934&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2011.09.071

DO - 10.1016/j.jconrel.2011.09.071

M3 - Article

C2 - 21945680

AN - SCOPUS:84855813934

VL - 157

SP - 224

EP - 234

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 2

ER -